| ■ 영문 제목 : Global Pancreatic Cancer Diagnostic Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02257 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 101 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 췌장암 진단의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (이미징, 종양 바이오마커, 생검, 기타)와 용도별 시장규모 (병원, 진료소, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 췌장암 진단 시장 점유율 - 지역별 췌장암 진단 시장규모 - 주요지역의 종류별 시장규모 (이미징, 종양 바이오마커, 생검, 기타) - 주요지역의 용도별 시장규모 (병원, 진료소, 기타) - 미주의 췌장암 진단 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 췌장암 진단 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 췌장암 진단 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 췌장암 진단 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 췌장암 진단 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Siemens, GE Healthcare, Roche, Philips Healthcare, Danaher, Canon Medical Systems, Abbott, Hitachi Medical, Qiagen, Myriad Genetics - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Pancreatic Cancer Diagnostic will have significant change from previous year. By the most conservative estimates of global Pancreatic Cancer Diagnostic market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 5143.6 million in 2020. Over the next five years the Pancreatic Cancer Diagnostic market will register a 7.6% CAGR in terms of revenue, the global market size will reach US$ 6882.5 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Pancreatic Cancer Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Imaging
Tumor Biomarker
Biopsy
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Siemens
GE Healthcare
Roche
Philips Healthcare
Danaher
Canon Medical Systems
Abbott
Hitachi Medical
Qiagen
Myriad Genetics
1 Scope of the Report 2 Executive Summary 3 Pancreatic Cancer Diagnostic Market Size by Players 4 Pancreatic Cancer Diagnostic by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global Pancreatic Cancer Diagnostic Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. Pancreatic Cancer Diagnostic Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Imaging Table 3. Major Players of Tumor Biomarker Table 4. Major Players of Biopsy Table 5. Major Players of Others Table 6. Pancreatic Cancer Diagnostic Market Size CAGR by Type (2020-2026) & ($ Millions) Table 7. Global Pancreatic Cancer Diagnostic Market Size by Type (2016-2021) & ($ Millions) Table 8. Global Pancreatic Cancer Diagnostic Market Size Market Share by Type (2016-2021) Table 9. Pancreatic Cancer Diagnostic Market Size CAGR by Application (2016-2021) & ($ Millions) Table 10. Global Pancreatic Cancer Diagnostic Market Size by Application (2016-2021) & ($ Millions) Table 11. Global Pancreatic Cancer Diagnostic Market Size Market Share by Application (2016-2021) Table 12. Global Pancreatic Cancer Diagnostic Revenue by Players (2019-2021E) & ($ Millions) Table 13. Global Pancreatic Cancer Diagnostic Revenue Market Share by Players (2019-2021E) Table 14. Pancreatic Cancer Diagnostic Key Players Head office and Products Offered Table 15. Pancreatic Cancer Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Pancreatic Cancer Diagnostic Market Size by Regions 2016-2021 & ($ Millions) Table 19. Global Pancreatic Cancer Diagnostic Market Size Market Share by Regions 2016-2021 Table 20. Americas Pancreatic Cancer Diagnostic Market Size by Country (2016-2021) & ($ Millions) Table 21. Americas Pancreatic Cancer Diagnostic Market Size Market Share by Country (2016-2021) Table 22. Americas Pancreatic Cancer Diagnostic Market Size by Type (2016-2021) & ($ Millions) Table 23. Americas Pancreatic Cancer Diagnostic Market Size Market Share by Type (2016-2021) Table 24. Americas Pancreatic Cancer Diagnostic Market Size by Application (2016-2021) & ($ Millions) Table 25. Americas Pancreatic Cancer Diagnostic Market Size Market Share by Application (2016-2021) Table 26. APAC Pancreatic Cancer Diagnostic Market Size by Region (2016-2021) & ($ Millions) Table 27. APAC Pancreatic Cancer Diagnostic Market Size Market Share by Region (2016-2021) Table 28. APAC Pancreatic Cancer Diagnostic Market Size by Type (2016-2021) & ($ Millions) Table 29. APAC Pancreatic Cancer Diagnostic Market Size Market Share by Type (2016-2021) Table 30. APAC Pancreatic Cancer Diagnostic Market Size by Application (2016-2021) & ($ Millions) Table 31. APAC Pancreatic Cancer Diagnostic Market Size Market Share by Application (2016-2021) Table 32. Europe Pancreatic Cancer Diagnostic Market Size by Country (2016-2021) & ($ Millions) Table 33. Europe Pancreatic Cancer Diagnostic Market Size Market Share by Country (2016-2021) Table 34. Europe Pancreatic Cancer Diagnostic Market Size by Type (2016-2021) & ($ Millions) Table 35. Europe Pancreatic Cancer Diagnostic Market Size Market Share by Type (2016-2021) Table 36. Europe Pancreatic Cancer Diagnostic Market Size by Application (2016-2021) & ($ Millions) Table 37. Europe Pancreatic Cancer Diagnostic Market Size Market Share by Application (2016-2021) Table 38. Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Region (2016-2021) & ($ Millions) Table 39. Middle East & Africa Pancreatic Cancer Diagnostic Market Size Market Share by Region (2016-2021) Table 40. Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Type (2016-2021) & ($ Millions) Table 41. Middle East & Africa Pancreatic Cancer Diagnostic Market Size Market Share by Type (2016-2021) Table 42. Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Application (2016-2021) & ($ Millions) Table 43. Middle East & Africa Pancreatic Cancer Diagnostic Market Size Market Share by Application (2016-2021) Table 44. Key and Potential Regions of Pancreatic Cancer Diagnostic Table 45. Key Application and Potential Industries of Pancreatic Cancer Diagnostic Table 46. Key Challenges of Pancreatic Cancer Diagnostic Table 47. Key Trends of Pancreatic Cancer Diagnostic Table 48. Global Pancreatic Cancer Diagnostic Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 49. Global Pancreatic Cancer Diagnostic Market Size Market Share Forecast by Regions (2021-2026) Table 50. Global Pancreatic Cancer Diagnostic Market Size Forecast by Type (2021-2026) & ($ Millions) Table 51. Global Pancreatic Cancer Diagnostic Market Size Market Share Forecast by Type (2021-2026) Table 52. Global Pancreatic Cancer Diagnostic Market Size Forecast by Application (2021-2026) & ($ Millions) Table 53. Global Pancreatic Cancer Diagnostic Market Size Market Share Forecast by Application (2021-2026) Table 54. Siemens Details, Company Type, Pancreatic Cancer Diagnostic Area Served and Its Competitors Table 55. Siemens Pancreatic Cancer Diagnostic Product Offered Table 56. Siemens Pancreatic Cancer Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 57. Siemens Main Business Table 58. Siemens Latest Developments Table 59. GE Healthcare Details, Company Type, Pancreatic Cancer Diagnostic Area Served and Its Competitors Table 60. GE Healthcare Pancreatic Cancer Diagnostic Product Offered Table 61. GE Healthcare Main Business Table 62. GE Healthcare Pancreatic Cancer Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 63. GE Healthcare Latest Developments Table 64. Roche Details, Company Type, Pancreatic Cancer Diagnostic Area Served and Its Competitors Table 65. Roche Pancreatic Cancer Diagnostic Product Offered Table 66. Roche Main Business Table 67. Roche Pancreatic Cancer Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 68. Roche Latest Developments Table 69. Philips Healthcare Details, Company Type, Pancreatic Cancer Diagnostic Area Served and Its Competitors Table 70. Philips Healthcare Pancreatic Cancer Diagnostic Product Offered Table 71. Philips Healthcare Main Business Table 72. Philips Healthcare Pancreatic Cancer Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 73. Philips Healthcare Latest Developments Table 74. Danaher Details, Company Type, Pancreatic Cancer Diagnostic Area Served and Its Competitors Table 75. Danaher Pancreatic Cancer Diagnostic Product Offered Table 76. Danaher Main Business Table 77. Danaher Pancreatic Cancer Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 78. Danaher Latest Developments Table 79. Canon Medical Systems Details, Company Type, Pancreatic Cancer Diagnostic Area Served and Its Competitors Table 80. Canon Medical Systems Pancreatic Cancer Diagnostic Product Offered Table 81. Canon Medical Systems Main Business Table 82. Canon Medical Systems Pancreatic Cancer Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 83. Canon Medical Systems Latest Developments Table 84. Abbott Details, Company Type, Pancreatic Cancer Diagnostic Area Served and Its Competitors Table 85. Abbott Pancreatic Cancer Diagnostic Product Offered Table 86. Abbott Main Business Table 87. Abbott Pancreatic Cancer Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 88. Abbott Latest Developments Table 89. Hitachi Medical Details, Company Type, Pancreatic Cancer Diagnostic Area Served and Its Competitors Table 90. Hitachi Medical Pancreatic Cancer Diagnostic Product Offered Table 91. Hitachi Medical Main Business Table 92. Hitachi Medical Pancreatic Cancer Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 93. Hitachi Medical Latest Developments Table 94. Qiagen Details, Company Type, Pancreatic Cancer Diagnostic Area Served and Its Competitors Table 95. Qiagen Pancreatic Cancer Diagnostic Product Offered Table 96. Qiagen Main Business Table 97. Qiagen Pancreatic Cancer Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 98. Qiagen Latest Developments Table 99. Myriad Genetics Details, Company Type, Pancreatic Cancer Diagnostic Area Served and Its Competitors Table 100. Myriad Genetics Pancreatic Cancer Diagnostic Product Offered Table 101. Myriad Genetics Main Business Table 102. Myriad Genetics Pancreatic Cancer Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 103. Myriad Genetics Latest Developments List of Figures Figure 1. Pancreatic Cancer Diagnostic Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Pancreatic Cancer Diagnostic Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Pancreatic Cancer Diagnostic Market Size Market Share by Type in 2020 Figure 7. Pancreatic Cancer Diagnostic in Hospitals Figure 8. Global Pancreatic Cancer Diagnostic Market: Hospitals (2016-2021) & ($ Millions) Figure 9. Pancreatic Cancer Diagnostic in Clinics Figure 10. Global Pancreatic Cancer Diagnostic Market: Clinics (2016-2021) & ($ Millions) Figure 11. Pancreatic Cancer Diagnostic in Others Figure 12. Global Pancreatic Cancer Diagnostic Market: Others (2016-2021) & ($ Millions) Figure 13. Global Pancreatic Cancer Diagnostic Market Size Market Share by Application in 2020 Figure 14. Global Pancreatic Cancer Diagnostic Revenue Market Share by Player in 2020 Figure 15. Global Pancreatic Cancer Diagnostic Market Size Market Share by Regions (2016-2021) Figure 16. Americas Pancreatic Cancer Diagnostic Market Size 2016-2021 ($ Millions) Figure 17. APAC Pancreatic Cancer Diagnostic Market Size 2016-2021 ($ Millions) Figure 18. Europe Pancreatic Cancer Diagnostic Market Size 2016-2021 ($ Millions) Figure 19. Middle East & Africa Pancreatic Cancer Diagnostic Market Size 2016-2021 ($ Millions) Figure 20. Americas Pancreatic Cancer Diagnostic Market Size Market Share by Country in 2020 Figure 21. Americas Pancreatic Cancer Diagnostic Market Size Market Share by Type in 2020 Figure 22. Americas Pancreatic Cancer Diagnostic Market Size Market Share by Application in 2020 Figure 23. United States Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 24. Canada Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 25. Mexico Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 26. APAC Pancreatic Cancer Diagnostic Market Size Market Share by Regions in 2020 Figure 27. APAC Pancreatic Cancer Diagnostic Market Size Market Share by Type in 2020 Figure 28. APAC Pancreatic Cancer Diagnostic Market Size Market Share by Application in 2020 Figure 29. China Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 30. Japan Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 31. Korea Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 32. Southeast Asia Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 33. India Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 34. Australia Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 35. Europe Pancreatic Cancer Diagnostic Market Size Market Share by Country in 2020 Figure 36. Europe Pancreatic Cancer Diagnostic Market Size Market Share by Type in 2020 Figure 37. Europe Pancreatic Cancer Diagnostic Market Size Market Share by Application in 2020 Figure 38. Germany Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 39. France Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 40. UK Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 41. Italy Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 42. Russia Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 43. Middle East & Africa Pancreatic Cancer Diagnostic Market Size Market Share by Region in 2020 Figure 44. Middle East & Africa Pancreatic Cancer Diagnostic Market Size Market Share by Type in 2020 Figure 45. Middle East & Africa Pancreatic Cancer Diagnostic Market Size Market Share by Application in 2020 Figure 46. Egypt Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 47. South Africa Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 48. Israel Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 49. Turkey Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 50. GCC Country Pancreatic Cancer Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 51. Americas Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 52. APAC Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 53. Europe Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 54. Middle East & Africa Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 55. United States Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 56. Canada Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 57. Mexico Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 58. Brazil Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 59. China Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 60. Japan Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 61. Korea Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 62. Southeast Asia Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 63. India Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 64. Australia Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 65. Germany Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 66. France Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 67. UK Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 68. Italy Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 69. Russia Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 70. Spain Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 71. Egypt Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 72. South Africa Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 73. Israel Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 74. Turkey Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) Figure 75. GCC Country Pancreatic Cancer Diagnostic Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 췌장암 진단 시장예측 2021년-2026년] (코드 : LPI-2201K02257) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 췌장암 진단 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |